Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis - A Systematic Review

Overview

Journal ACR Open Rheumatol

Date 2020 Feb 12

PMID 32043830

Citations 1

Authors

Sohail Farshad

Alexandra Halalau

Whitney Townsend

Elena Schiopu

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the current state of knowledge for the utility of coronary calcium scoring (CCS) in connective tissue disorders (CTDs) as it relates to the presence and quantification of coronary atherosclerosis.

Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a literature search via PubMed, Embase, Scopus, Web of Science Core Collection, CINAHL, and Cochrane Database of Systematic Review retrieved 1019 studies (since database inception on May 7, 2018) from which 121 manuscripts were eligible for review. Inclusion criteria consisted of studies that investigated CCS in adults with respective CTDs. Studies were excluded if a complete manuscript was not written in English or was a case report.

Results: Thirty-one studies were included (27 with healthy age-/gender-matched control group for comparison and 4 without). CTDs analyzed in articles with control group: 11 rheumatoid arthritis (RA), 14 systemic lupus erythematosus (SLE), 4 systemic sclerosis (SSc), 1 idiopathic inflammatory myopathies (IIM), 1 Takayasu arteritis, and 1 psoriasis. Nine out of 11 RA studies, 12 out of 14 SLE studies, and 2 out of 4 SSc studies showed statistically significant increased CCS when compared with the control group. CTDs analyzed in studies without control group: two Kawasaki disease, one juvenile idiopathic arthritis (JIA), and one antiphospholipid syndrome (APS) article, which demonstrated increased coronary arterial calcium burden, however, without statistically significant data.

Conclusion: CTDs, especially SLE and RA, are associated with higher CCS compared with the control group, indicating increased risk of coronary atherosclerosis. Our search did not elicit sufficient publications or statistically significant results in many other CTDs.

Citing Articles

Computed Tomography (CT) Calcium Scoring in Primary Prevention of Acute Coronary Syndrome and Future Cardiac Events in Patients With Systemic Lupus Erythematosus.

Wu M, Mirkin S, Nagy S, McPhail M, Demory Beckler M, Kesselman M Cureus. 2023; 15(10):e47157.

PMID: 38022274 PMC: 10653626. DOI: 10.7759/cureus.47157.

References

Giles J, Szklo M, Post W, Petri M, Blumenthal R, Lam G . Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther. 2009; 11(2):R36. PMC: 2688181. DOI: 10.1186/ar2641. View

Ali H, Ng K, Low A . A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis. Int J Rheum Dis. 2015; 18(3):276-86. DOI: 10.1111/1756-185X.12566. View

Kahn A, Budoff M, Daniels L, Oyamada J, Gordon J, Burns J . Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease. Am J Cardiol. 2017; 119(7):967-971. PMC: 5348258. DOI: 10.1016/j.amjcard.2016.11.055. View

Paccou J, Renard C, Liabeuf S, Kamel S, Fardellone P, Massy Z . Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments. J Rheumatol. 2014; 41(11):2137-44. DOI: 10.3899/jrheum.140239. View

Khurma V, Meyer C, Park G, McMahon M, Lin J, Singh R . A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum. 2008; 59(4):591-7. DOI: 10.1002/art.23540. View

Agatston A, Janowitz W, HILDNER F, Zusmer N, VIAMONTE Jr M, Detrano R . Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15(4):827-32. DOI: 10.1016/0735-1097(90)90282-t. View

Budoff M, Young R, Lopez V, Kronmal R, Nasir K, Blumenthal R . Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013; 61(12):1231-9. PMC: 4148074. DOI: 10.1016/j.jacc.2012.12.035. View

Asanuma Y, Chung C, Oeser A, Solus J, Avalos I, Gebretsadik T . Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007; 195(2):e135-41. PMC: 2174431. DOI: 10.1016/j.atherosclerosis.2007.04.049. View

Asanuma Y, Oeser A, Shintani A, Turner E, Olsen N, Fazio S . Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349(25):2407-15. DOI: 10.1056/NEJMoa035611. View

10.

Romero-Diaz J, Acosta-Hernandez R, Criales-Vera S, Kimura-Hayama E, Dominguez-Quintana M, Moran-Contla R . Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus. J Rheumatol. 2018; 45(5):663-670. DOI: 10.3899/jrheum.170330. View

11.

Chung C, Solus J, Oeser A, Avalos I, Kurnik D, Raggi P . N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification. J Rheumatol. 2008; 35(7):1314-9. PMC: 2754266. View

12.

Montecucco F, Mach F . Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford). 2008; 48(1):11-22. DOI: 10.1093/rheumatology/ken395. View

13.

Majka D, Liu K, Pope R, Karlson E, Vu T, Teodorescu M . Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Inflamm Res. 2013; 62(10):919-27. PMC: 4122510. DOI: 10.1007/s00011-013-0652-x. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

15.

Chung C, Giles J, Kronmal R, Post W, Gelber A, Petri M . Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther. 2013; 15(5):R134. PMC: 3978773. DOI: 10.1186/ar4314. View

16.

Pletcher M, Tice J, Pignone M, Browner W . Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med. 2004; 164(12):1285-92. DOI: 10.1001/archinte.164.12.1285. View

17.

Diederichsen L, Diederichsen A, Simonsen J, Junker P, Sondergaard K, Lundberg I . Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study. Arthritis Care Res (Hoboken). 2014; 67(6):848-54. DOI: 10.1002/acr.22520. View

18.

Baena-Diez J, Garcia-Gil M, Comas-Cufi M, Ramos R, Prieto-Alhambra D, Salvador-Gonzalez B . Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2017; 104(2):119-126. DOI: 10.1136/heartjnl-2017-311279. View

19.

Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

20.

Romero-Diaz J, Vargas-Vorackova F, Kimura-Hayama E, Cortazar-Benitez L, Gijon-Mitre R, Criales S . Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford). 2011; 51(1):110-9. DOI: 10.1093/rheumatology/ker307. View